Episode Details
Back to Episodes
Managing Pancreatic Neuroendocrine Tumors
Description
Not all pancreatic cancers are the same. While most patients are diagnosed with pancreatic adenocarcinoma, approximately 10% have pancreatic neuroendocrine tumors (PNETs). What makes PNETs different, and what does that mean for diagnosis, treatment, and care?
On this episode of PancChat, host Alisyn Camerota joins Dr. Diane Reidy-Lagunes, chief of the Division of Medical Oncology and vice president for oncology services at Duke University Health System, to explore the biology, symptoms, treatment, and outlook of PNETs.
Dr. Reidy-Lagunes explains why some PNETs can be monitored while others need treatment, how tumor grade helps guide care, and how expanding treatment options are helping many patients live for years – even with advanced disease. They also discuss emerging research and why a second opinion from a team with neuroendocrine expertise can help patients navigate their options.
PancChat is sponsored by Revolution Medicines and produced in collaboration with Let’s Win Pancreatic Cancer and PanCAN.
Resources:
Let's Win Pancreatic Cancer
PanCAN
Let's Win Clinical Trial Finder
PanCAN Clinical Trial Finder
Let's Win Doctor Finder
PanCAN Patient Services